Central Nervous System Pharmacology Practice Questions

Q: Spina bifida is a known complication associated with the use of which medication?

Carbamazepine. **Explanation:** The correct answer is **Carbamazepine**. **1. Why Carbamazepine is Correct:** Carbamazepine is a classic enzyme-inducing anticonvulsant. It is a known human teratogen associated with a 1% risk of **Neural Tube Defects (NTDs)**, specifically **Spina Bifida**. The underlying mechanism involves the drug’s interference with **folate metabolism** and the production of reactive epoxide metabolites. When taken during the first trimester (the period of organogenesis), it inhibits the proper closure of the neural tube. **2. Why the Other Options are Incorrect:** * **Clozapine & Olanzapine:** These are atypical antipsychotics. They are generally not associated with structural malformations like Spina Bifida. Their primary concern in pregnancy is metabolic (e.g., gestational diabetes and excessive weight gain). * **Lithium:** This mood stabilizer is classically associated with **Ebstein’s Anomaly**, a congenital cardiac defect involving the tricuspid valve, rather than neural tube defects. **3. High-Yield Clinical Pearls for NEET-PG:** * **Valproate vs. Carbamazepine:** While both cause Spina Bifida, **Sodium Valproate** carries the highest risk (approx. 2-5%) and is the most common cause of drug-induced NTDs. * **Prevention:** To reduce the risk of NTDs in women taking antiepileptic drugs (AEDs), high-dose **Folic Acid (4-5 mg/day)** supplementation is recommended starting before conception. * **Fetal Hydantoin Syndrome:** Associated with **Phenytoin**, characterized by craniofacial anomalies, hypoplastic nails, and phalanges. * **Safe AEDs in Pregnancy:** Levetiracetam and Lamotrigine are currently considered to have the lowest teratogenic potential.

Q: A teenager presents with persistent and severe headaches. The physician diagnoses migraine and prescribes sumatriptan. By which of the following mechanisms does sumatriptan act?

Serotonin 1D agonist. **Explanation:** **Mechanism of Action (Correct Option):** Sumatriptan is a selective **5-HT$_{1B/1D}$ receptor agonist**. It is the prototype of the "Triptan" class used for the acute management of migraine. Its therapeutic effect is mediated via three primary mechanisms: 1. **Vasoconstriction:** Activation of 5-HT$_{1B}$ receptors on intracranial blood vessels leads to the constriction of painfully dilated meningeal vessels. 2. **Inhibition of Neuropeptides:** Activation of 5-HT$_{1D}$ receptors on trigeminal nerve terminals inhibits the release of pro-inflammatory neuropeptides (e.g., Calcitonin Gene-Related Peptide or CGRP and Substance P). 3. **Central Inhibition:** It reduces the transmission of pain signals through the trigeminal nucleus caudalis. **Analysis of Incorrect Options:** * **Option A (D1 Agonist):** Dopamine agonists (like Fenoldopam) are used in hypertensive emergencies or Parkinson’s disease. In migraine, dopamine *antagonists* (e.g., Metoclopramide) are used as adjuncts to treat nausea and enhance gastric emptying. * **Option B (GABA$_B$ Antagonist):** GABA$_B$ agonists (like Baclofen) are muscle relaxants. Antagonists have no established role in migraine therapy. * **Option C (M3 Antagonist):** These drugs (e.g., Oxybutynin) are used for overactive bladder or COPD. Anticholinergics are not indicated for migraine. **Clinical Pearls for NEET-PG:** * **Drug of Choice:** Triptans are the DOC for **acute severe migraine** attacks but are *not* used for prophylaxis. * **Contraindications:** Due to their vasoconstrictive properties, they are strictly contraindicated in patients with **Ischemic Heart Disease (Prinzmetal angina/MI)**, uncontrolled hypertension, and peripheral vascular disease. * **Serotonin Syndrome:** Caution is required when co-administered with SSRIs or MAO inhibitors.

Q: Which of the following drugs is NOT used in the management of Alzheimer's disease?

Clonidine. **Explanation:** The management of Alzheimer’s Disease (AD) primarily focuses on enhancing cholinergic transmission or modulating glutamatergic excitability. **Clonidine** is the correct answer because it is a **centrally acting alpha-2 ($\alpha_2$) adrenergic agonist** used primarily for hypertension, ADHD, and opioid withdrawal; it has no role in treating the cognitive decline of Alzheimer’s. **Analysis of Options:** * **Rivastigmine & Donepezil (Options A & C):** These are **Centrally acting Reversible Acetylcholinesterase Inhibitors (AChEIs)**. Alzheimer’s is characterized by a deficiency of acetylcholine in the nucleus basalis of Meynert. These drugs increase synaptic acetylcholine levels, improving cognitive function in mild-to-moderate AD. *Note: Rivastigmine is unique as it inhibits both AChE and Butyrylcholinesterase.* * **Memantine (Option B):** This is an **NMDA receptor antagonist**. It prevents glutamate-induced excitotoxicity, which leads to neuronal death in AD. It is typically used for moderate-to-severe cases, often in combination with Donepezil. **High-Yield Clinical Pearls for NEET-PG:** 1. **Donepezil** is the most commonly used AChEI due to its once-daily dosing and better tolerability. 2. **Galantamine** is another AChEI used in AD that also acts as a nicotinic receptor modulator. 3. **Side Effects of AChEIs:** Primarily GI-related (nausea, diarrhea) and bradycardia (SLUDGE effects). 4. **Newer Drugs:** **Aducanumab** and **Lecanemab** (monoclonal antibodies against amyloid-beta plaques) are recent FDA-approved disease-modifying therapies. 5. **Clonidine Side Effects:** Sedation, dry mouth (xerostomia), and rebound hypertension if stopped abruptly.

Q: Which Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) is used to treat pain associated with diabetic neuropathy?

Duloxetine. **Explanation:** **Duloxetine** is a potent Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) that is FDA-approved for the management of chronic pain conditions, specifically **diabetic peripheral neuropathic pain (DPNP)**, fibromyalgia, and chronic musculoskeletal pain. Its efficacy stems from its ability to enhance descending inhibitory pain pathways in the spinal cord by increasing the synaptic concentration of both serotonin and norepinephrine. **Analysis of Options:** * **Duloxetine (Correct):** It is the first-line SNRI for diabetic neuropathy. It has a balanced inhibition of both reuptake transporters and is preferred due to extensive clinical evidence for neuropathic pain. * **Clomipramine:** This is a Tricyclic Antidepressant (TCA). While TCAs are used off-label for neuropathy, Clomipramine is primarily used for Obsessive-Compulsive Disorder (OCD) and is not an SNRI. * **Venlafaxine:** Although it is an SNRI used off-label for neuropathic pain, it is not the primary choice or the specific answer sought for "approved" indications in this context. At lower doses, it acts primarily as an SSRI; its norepinephrine effect only becomes significant at higher doses. * **Desvenlafaxine:** The active metabolite of venlafaxine. While it is an SNRI, it is primarily indicated for Major Depressive Disorder and lacks the robust clinical labeling for diabetic neuropathy that duloxetine possesses. **High-Yield Pearls for NEET-PG:** * **First-line drugs for Diabetic Neuropathy:** Duloxetine (SNRI), Pregabalin/Gabapentin (Calcium channel α2-δ ligands), and Amitriptyline (TCA). * **Duloxetine Side Effects:** Nausea (most common), dry mouth, and somnolence. It should be avoided in patients with chronic liver disease. * **Mechanism:** SNRIs treat pain by increasing norepinephrine in the **descending antinociceptive pathway**, which inhibits the transmission of pain signals from the periphery to the brain.

Q: Which of the following anti-Parkinson drugs can lead to the adverse effect described?

Amantadine. ***Amantadine*** - Causes **livedo reticularis** (net-like, mottled purplish skin discoloration) due to its **anticholinergic properties** and effects on peripheral blood flow. - This distinctive **dermatological adverse effect** occurs in up to 90% of patients on long-term amantadine therapy and is reversible upon discontinuation. *Ropinirole* - A **dopamine agonist** that primarily causes **nausea, orthostatic hypotension**, and **impulse control disorders** like gambling. - Does not cause **livedo reticularis** as it lacks the anticholinergic and vascular effects seen with amantadine. *Tolcapone* - A **COMT inhibitor** that can cause severe **hepatotoxicity** requiring regular liver function monitoring. - Main adverse effects include **dyskinesia, nausea**, and **orange discoloration of urine**, not skin mottling. *Selegiline* - A **MAO-B inhibitor** that can cause **insomnia, orthostatic hypotension**, and **serotonin syndrome** when combined with certain antidepressants. - Does not affect **peripheral circulation** or cause the characteristic skin changes associated with amantadine.

Q: A patient with a history of hepatitis one month ago should preferably be given which local anesthetic agent?

Procaine. **Explanation:** The core concept tested here is the **site of metabolism** of local anesthetics (LAs). Local anesthetics are classified into two groups: **Amides** and **Esters**. 1. **Why Procaine is Correct:** Procaine is an **ester-linked** local anesthetic. Esters are primarily metabolized by **pseudocholinesterase (plasma cholinesterase)** in the blood. Since the liver is not the primary site of metabolism for esters, Procaine is the safest choice for a patient with recent hepatitis or compromised liver function. 2. **Why the other options are incorrect:** * **Lignocaine (Lidocaine) & Bupivacaine:** These are **amide-linked** local anesthetics (identified by the "i" before the "-caine"). Amides are metabolized almost exclusively by **hepatic microsomal enzymes** (Cytochrome P450). In a patient with a history of hepatitis, hepatic clearance is reduced, significantly increasing the risk of systemic toxicity (LAST). * **Procainamide:** While it sounds similar to procaine, it is a Class 1A antiarrhythmic agent, not a primary local anesthetic used for regional blocks. **NEET-PG High-Yield Pearls:** * **Mnemonic:** Amides have two "i"s in their name (L**i**doca**i**ne, Bup**i**vaca**i**ne, Pr**i**loca**i**ne, Rop**i**vaca**i**ne), whereas Esters have only one (Proca**i**ne, Chloroproca**i**ne, Coca**i**ne, Tetraca**i**ne). * **Exception:** Cocaine is an ester but is partially metabolized in the liver. * **Prilocaine** is associated with **methemoglobinemia** due to its metabolite, o-toluidine. * **Bupivacaine** is the most cardiotoxic LA; **Levobupivacaine** and **Ropivacaine** are safer alternatives with less cardiotoxicity.

Q: Which of the following drugs can be used as a transcranial patch for the treatment of parkinsonism?

Rotigotine. **Explanation:** **Rotigotine** is a non-ergot dopamine agonist (D2, D3, and D1 receptor stimulator) specifically designed for **transdermal delivery**. It is highly lipophilic, allowing it to be formulated as a once-daily **transdermal patch**. This delivery method provides continuous drug delivery over 24 hours, maintaining stable plasma levels and avoiding the "pulsatile" stimulation of dopamine receptors associated with oral medications, which helps in reducing motor fluctuations in Parkinson’s disease. **Analysis of Incorrect Options:** * **Levodopa (A):** It is the precursor of dopamine and the most effective drug for Parkinsonism. However, it has a short half-life and requires active transport across the gut and blood-brain barrier; it is not available as a patch. * **Apomorphine (C):** A potent dopamine agonist used as "rescue therapy" for acute "off" episodes. Due to extensive first-pass metabolism, it cannot be given orally. It is administered via **subcutaneous injection** or continuous infusion, not a patch. * **Aprantine (D):** This is a distractor. It is not a recognized drug for the treatment of Parkinson’s disease. **High-Yield Clinical Pearls for NEET-PG:** * **Rotigotine Patch:** Useful for patients with dysphagia or those requiring stable nocturnal symptom control. * **Dopamine Agonists:** Divided into Ergot (Bromocriptine, Pergolide) and Non-ergot (Pramipexole, Ropinirole, Rotigotine). Non-ergot derivatives are preferred due to the lack of risk for cardiac valvular fibrosis. * **Side Effects:** Like other dopamine agonists, Rotigotine can cause impulse control disorders (pathological gambling, hypersexuality) and sudden sleep attacks.

Q: A 10-year-old boy presents with difficulty in learning at school. He experiences short lapses of awareness with eyelid fluttering every 5–10 minutes. EEG studies reveal brief 3 Hz spike and wave discharges appearing synchronously in all leads. Which of the following drugs would be effective but has the disadvantage that it causes sedation and tolerance?

Clonazepam. **Explanation:** The clinical presentation of short lapses of awareness, eyelid fluttering, and the characteristic **3 Hz spike-and-wave discharges** on EEG is diagnostic of **Absence Seizures (Petit Mal)**. **Why Clonazepam is the correct answer:** While Ethosuximide and Valproate are the preferred first-line treatments for absence seizures, the question specifically asks for a drug that is effective but limited by **sedation and the development of tolerance**. **Clonazepam**, a benzodiazepine, fits this profile perfectly. It is highly effective in suppressing absence seizures but is rarely used as a first-line agent because patients quickly develop tolerance to its anti-seizure effects, and it causes significant CNS depression (sedation). **Analysis of Incorrect Options:** * **Ethosuximide (B):** This is the drug of choice for pure absence seizures. It works by blocking T-type Ca²⁺ channels. It does *not* typically cause significant tolerance. * **Valproic acid (D):** The drug of choice for absence seizures associated with generalized tonic-clonic seizures (GTCS). While it has side effects (hepatotoxicity, weight gain), tolerance is not a primary clinical concern. * **Diazepam (A):** While a benzodiazepine, it is primarily used for the acute management of Status Epilepticus (IV) or febrile seizures (rectal). It is not used for the long-term maintenance therapy of absence seizures. **High-Yield NEET-PG Pearls:** * **DOC for Absence Seizures:** Ethosuximide (if pure); Valproate (if mixed with GTCS). * **Mechanism of Ethosuximide:** Inhibition of T-type Calcium channels in thalamic neurons. * **Drugs that Aggravate Absence Seizures:** Phenytoin, Carbamazepine, and Vigabatrin. * **Benzodiazepine Limitation:** The main drawback of using BDZs like Clonazepam or Nitrazepam in chronic epilepsy is **tolerance** (downregulation of GABA-A receptors).

Question 1

Which of the following is not a side effect of phenytoin?

Accepted Answer

Hypoglycemia

Answer

Osteomalacia

Answer

Gum hypertrophy

Answer

Lymphadenopathy

Question 2

Which of the following conditions makes the nerve membrane more susceptible to the action of local anesthetics?

Accepted Answer

Increased extracellular potassium

Answer

Increased extracellular calcium

Answer

Increased extracellular sodium

Answer

Decreased extracellular chloride

Question 3

Spina bifida is a known complication associated with the use of which medication?

Accepted Answer

Carbamazepine

Answer

Clozapine

Answer

Lithium

Answer

Olanzapine

Question 4

A teenager presents with persistent and severe headaches. The physician diagnoses migraine and prescribes sumatriptan. By which of the following mechanisms does sumatriptan act?

Accepted Answer

Serotonin 1D agonist

Answer

Dopamine 1 agonist

Answer

GABAB antagonist

Answer

Muscarinic 3 antagonist

Question 5

Which of the following drugs is NOT used in the management of Alzheimer's disease?

Accepted Answer

Clonidine

Answer

Rivastigmine

Answer

Memantine

Answer

Donepezil

Question 6

Which Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) is used to treat pain associated with diabetic neuropathy?

Accepted Answer

Duloxetine

Answer

Clomipramine

Answer

Venlafaxine

Answer

Desvenlafaxine

Question 7

Which of the following anti-Parkinson drugs can lead to the adverse effect described?

Accepted Answer

Amantadine

Answer

Ropinirole

Answer

Tolcapone

Answer

Selegiline

Question 8

A patient with a history of hepatitis one month ago should preferably be given which local anesthetic agent?

Accepted Answer

Procaine

Answer

Lignocaine

Answer

Bupivacaine

Answer

Procainamide

Question 9

Which of the following drugs can be used as a transcranial patch for the treatment of parkinsonism?

Accepted Answer

Rotigotine

Answer

Levodopa

Answer

Apomorphine

Answer

Aprantine

Question 10

A 10-year-old boy presents with difficulty in learning at school. He experiences short lapses of awareness with eyelid fluttering every 5–10 minutes. EEG studies reveal brief 3 Hz spike and wave discharges appearing synchronously in all leads. Which of the following drugs would be effective but has the disadvantage that it causes sedation and tolerance?

Accepted Answer

Clonazepam

Answer

Diazepam

Answer

Ethosuximide

Answer

Valproic acid

Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?